Beacon Pointe Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
OAG
Beacon Pointe Wealth Advisors's ABBV Position: Q4 2019 in Review
Beacon Pointe Wealth Advisors increased its AbbVie (ABBV) stake by 0.51% in Q4 2019, buying an estimated $4.9K and bringing the position to 11,727 shares worth $1.04M. The position accounts for 0.19% of the portfolio, ranked #102.
Beacon Pointe Wealth Advisors first reported a position in ABBV in Q4 2018 and has held it in 5 quarters since. The position peaked at $1.47M in Q4 2018. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.
- Beacon Pointe Wealth Advisors held 11,727 shares of AbbVie worth $1.04M as of Q4 2019.
- Beacon Pointe Wealth Advisors bought 59 AbbVie shares in Q4 2019, an estimated $4.9K.
- AbbVie made up 0.19% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #102 holding.
- Beacon Pointe Wealth Advisors first reported a position in AbbVie in Q4 2018 and has held it in 5 quarters since.
- Beacon Pointe Wealth Advisors's AbbVie position peaked at $1.47M in Q4 2018.
- 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.
Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.